Company Overview

Name Noevir Holdings Co., Ltd.


6-13-1 Minatojima-Nakamachi, Chuo-ku, Kobe 650-8521, Japan

7-6-15 Ginza, Chuo-ku, Tokyo 104-8208, Japan

Date of Establishment

March 22, 2011 (Noevir Co., Ltd was founded in April 1964.)

Paid-in Capital

¥7,319 million

Fiscal Year End

September 30

List of Directors

Chairman and Representative Director
Hiroshi Okura
President and CEO
Takashi Okura
Managing Director
Ikkou Yoshida
Yasuo Kaiden
Masataka Nakano
Outside Director
Sanae Tanaka
Outside Director
Maho Kinami
Outside Director
Emima Abe
Outside Director
Ryo Tsuchida
Outside Director
Mari Ishimitsu
Outside Director
Haruhi Kuroda
Audit & Supervisory Board Member
Masayuki Hamaguchi
Outside Audit & Supervisory Board Member
Kazuya Sugimoto
Outside Audit & Supervisory Board Member
Kayo Sato
※As of Dec. 6, 2021

Line of Business

Business management of the entire group


65(Unconsolidated) , 1,453(Consolidated) ※As of Sep. 30, 2021

Consolidated Subsidiaries

6 domestic / 7 international

Stock Listing

Tokyo Stock Exchange (Prime Market) [Stock Code 4928]


In March, 2011

Noevir Co., Ltd. established a holding company, Noevir Holdings Co., Ltd., by transfer of stock.

In August, 2012

The listing was changed from the Second Section to the First Section of the Tokyo Stock Exchange.

In April, 2022

Transition to the Prime Market of the Tokyo Stock Exchange.